{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:15:43Z","timestamp":1792401343214,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.prostaglandins.2009.03.002","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T09:04:33Z","timestamp":1238058273000},"page":"126-130","source":"Crossref","is-referenced-by-count":98,"title":["Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1"],"prefix":"10.1016","volume":"89","author":[{"given":"Hiroyuki","family":"Seki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6917","key":"10.1016\/j.prostaglandins.2009.03.002_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.prostaglandins.2009.03.002_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.291.5.585","article-title":"C-reactive protein and the risk of incident colorectal cancer","volume":"291","author":"Erlinger","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.prostaglandins.2009.03.002_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S0029665107005472","article-title":"Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease","volume":"66","author":"Sijben","year":"2007","journal-title":"Proc Nutr Soc"},{"issue":"12","key":"10.1016\/j.prostaglandins.2009.03.002_bib4","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.80.12.3581","article-title":"Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis","volume":"80","author":"Corey","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8081","key":"10.1016\/j.prostaglandins.2009.03.002_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(78)91505-2","article-title":"Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?","volume":"2","author":"Dyerberg","year":"1978","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.prostaglandins.2009.03.002_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.76.2.944","article-title":"Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties","volume":"76","author":"Needleman","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.prostaglandins.2009.03.002_bib7","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1016\/S0021-9258(17)42835-3","article-title":"The effect of eicosapentaenoic acid on leukotriene B production by human neutrophils","volume":"259","author":"Prescott","year":"1984","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.prostaglandins.2009.03.002_bib8","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1172\/JCI111612","article-title":"Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils","volume":"74","author":"Lee","year":"1984","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.prostaglandins.2009.03.002_bib9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.prostaglandins.2009.03.002_bib10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"issue":"17","key":"10.1016\/j.prostaglandins.2009.03.002_bib11","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J Biol Chem"},{"issue":"6974","key":"10.1016\/j.prostaglandins.2009.03.002_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/427504a","article-title":"Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids","volume":"427","author":"Kang","year":"2004","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.prostaglandins.2009.03.002_bib13","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1073\/pnas.0601280103","article-title":"Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis","volume":"103","author":"Hudert","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.prostaglandins.2009.03.002_bib14","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1158\/0008-5472.CAN-07-6251","article-title":"Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice","volume":"68","author":"Jia","year":"2008","journal-title":"Cancer Res"},{"issue":"9177","key":"10.1016\/j.prostaglandins.2009.03.002_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.prostaglandins.2009.03.002_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.prostaglandins.2009.03.002_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/09629359990298","article-title":"The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP","volume":"8","author":"Akarasereenont","year":"1999","journal-title":"Mediators Inflamm"},{"issue":"11","key":"10.1016\/j.prostaglandins.2009.03.002_bib18","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.chembiol.2006.09.011","article-title":"Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis","volume":"13","author":"Tjonahen","year":"2006","journal-title":"Chem Biol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2009.03.002_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2005.07.181","article-title":"The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids","volume":"338","author":"Arita","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.prostaglandins.2009.03.002_bib20","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1371\/journal.pone.0001316","article-title":"Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator Resolvin E1","volume":"2","author":"Haas-Stapleton","year":"2007","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.prostaglandins.2009.03.002_bib21","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.4049\/jimmunol.180.5.3512","article-title":"Resolvin E1 metabolome in local inactivation during inflammation-resolution","volume":"180","author":"Hong","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.prostaglandins.2009.03.002_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.pathol.2.010506.091944","article-title":"Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury","volume":"2","author":"Chin","year":"2007","journal-title":"Annu Rev Pathol"},{"issue":"7146","key":"10.1016\/j.prostaglandins.2009.03.002_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.prostaglandins.2009.03.002_bib24","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.0409271102","article-title":"Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis","volume":"102","author":"Arita","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.prostaglandins.2009.03.002_bib25","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1096\/fj.07-8473com","article-title":"Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution","volume":"21","author":"Campbell","year":"2007","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.prostaglandins.2009.03.002_bib26","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.prostaglandins.2009.03.002_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/ni.1627","article-title":"Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A(4) to promote the resolution of allergic airway inflammation","author":"Haworth","year":"2008","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.prostaglandins.2009.03.002_bib28","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.4049\/jimmunol.181.7.4534","article-title":"Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells","volume":"181","author":"Vassiliou","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.prostaglandins.2009.03.002_bib29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood-2007-11-122598","article-title":"Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets","volume":"112","author":"Dona","year":"2008","journal-title":"Blood"},{"issue":"8140","key":"10.1016\/j.prostaglandins.2009.03.002_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(79)91490-9","article-title":"Haemostatic function and platelet polyunsaturated fatty acids in Eskimos","volume":"2","author":"Dyerberg","year":"1979","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.prostaglandins.2009.03.002_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1096\/fj.05-4724fje","article-title":"RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis","volume":"20","author":"Hasturk","year":"2006","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.prostaglandins.2009.03.002_bib32","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.4049\/jimmunol.179.10.7021","article-title":"Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo","volume":"179","author":"Hasturk","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.prostaglandins.2009.03.002_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jama.285.5.643","article-title":"Prospects for research in inflammatory bowel disease","volume":"285","author":"Blumberg","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.prostaglandins.2009.03.002_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.prostaglandins.2009.03.002_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2008.01.012","article-title":"Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma","volume":"367","author":"Aoki","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"6760 Suppl.","key":"10.1016\/j.prostaglandins.2009.03.002_bib36","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1038\/35037000","article-title":"The epidemic of allergy and asthma","volume":"402","author":"Holgate","year":"1999","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.prostaglandins.2009.03.002_bib37","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.prostaglandins.2009.03.002_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1189\/jlb.0503247","article-title":"IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic, asthmatic patients by inducing Fas\/FasL-mediated apoptosis","volume":"76","author":"De Rose","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"8","key":"10.1016\/j.prostaglandins.2009.03.002_bib39","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1096\/fasebj.13.8.903","article-title":"Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a \u2018stop\u2019 signaling switch for aspirin-triggered lipoxin A4","volume":"13","author":"Levy","year":"1999","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.prostaglandins.2009.03.002_bib40","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm748","article-title":"Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4)","volume":"8","author":"Levy","year":"2002","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.prostaglandins.2009.03.002_bib41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.prostaglandins.2009.03.002_bib42","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.4049\/jimmunol.177.9.5902","article-title":"Resolvin D series and protectin D1 mitigate acute kidney injury","volume":"177","author":"Duffield","year":"2006","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.prostaglandins.2009.03.002_bib43","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J Biol Chem"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882309000173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882309000173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T12:36:21Z","timestamp":1633264581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882309000173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":43,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1098882309000173"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2009.03.002","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}